Korean Circ J.  2019 Jan;49(1):81-83. 10.4070/kcj.2018.0285.

Stent Selection in Complex Coronary Interventions: Thinking Complex?

• Lee PH
• Lee SW

• KMID: 2430750
• DOI: http://doi.org/10.4070/kcj.2018.0285

Abstract

No abstract available.

MeSH Terms

Stents*
Thinking*

Reference

1. Stefanini GG, Taniwaki M, Windecker S. Coronary stents: novel developments. Heart. 2014; 100:1051–1061.

2. Byrne RA, Stone GW, Ormiston J, Kastrati A. Coronary balloon angioplasty, stents, and scaffolds. Lancet. 2017; 390:781–792.

3. Werner N, Nickenig G, Sinning JM. Complex PCI procedures: challenges for the interventional cardiologist. Clin Res Cardiol. 2018; 107:Suppl 2. 64–73.

4. Piccolo R, Giustino G, Mehran R, Windecker S. Stable coronary artery disease: revascularisation and invasive strategies. Lancet. 2015; 386:702–713.

5. Song PS, Park KT, Kim MJ, et al. Safety and efficacy of biodegradable polymer-biolimus-eluting stents (BP-BES) compared with durable polymer-everolimus-eluting stents (DP-EES) in patients undergoing complex percutaneous coronary intervention. Korean Circ J. 2018; 69–80.

6. Yeh RW, Kereiakes DJ, Steg PG, et al. Lesion complexity and outcomes of extended dual antiplatelet therapy after percutaneous coronary intervention. J Am Coll Cardiol. 2017; 70:2213–2223.

7. Giustino G, Chieffo A, Palmerini T, et al. Efficacy and safety of dual antiplatelet therapy after complex PCI. J Am Coll Cardiol. 2016; 68:1851–1864.

8. Lee SY, Hong MK, Jang Y. Formation and transformation of neointima after drug-eluting stent implantation: insights from optical coherence tomographic studies. Korean Circ J. 2017; 47:823–832.

9. Windecker S, Serruys PW, Wandel S, et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet. 2008; 372:1163–1173.

10. Serruys PW, Farooq V, Kalesan B, et al. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. JACC Cardiovasc Interv. 2013; 6:777–789.